Search research articles
Contact Us
Filters
Showing results (61-70 of 64) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 64 results.
Communications Medicine
|
May 22, 2024
Structure-specific rigid dose accumulation dosimetric analysis of ablative stereotactic MRI-guided adaptive radiation therapy in ultracentral lung lesions
J M Bryant, Ruben J Cruz-Chamorro, Alberic Gan, et al.
Biorxiv : the Preprint Server for Biology
|
October 28, 2024
Nanoparticles use magnetoelectricity to target and eradicate cancer cells
John Michael Bryant, Emmanuel Stimphil, Victoria Andre, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
November 3, 2025
Magnetoelectric Nanotherapy Achieves Complete Tumor Ablation and Prolonged Survival in Pancreatic Cancer Murine Models
John Michael Bryant, Max Shotbolt, Emmanuel Stimphil, et al.
BMC Cancer
|
April 9, 2024
Habitat escalated adaptive therapy (HEAT): a phase 2 trial utilizing radiomic habitat-directed and genomic-adjusted radiation dose (GARD) optimization for high-grade soft tissue sarcoma
Arash O Naghavi, J M Bryant, Youngchul Kim, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 64) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 64 results.
Communications Medicine
|
May 22, 2024
Structure-specific rigid dose accumulation dosimetric analysis of ablative stereotactic MRI-guided adaptive radiation therapy in ultracentral lung lesions
J M Bryant, Ruben J Cruz-Chamorro, Alberic Gan, et al.
Biorxiv : the Preprint Server for Biology
|
October 28, 2024
Nanoparticles use magnetoelectricity to target and eradicate cancer cells
John Michael Bryant, Emmanuel Stimphil, Victoria Andre, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
November 3, 2025
Magnetoelectric Nanotherapy Achieves Complete Tumor Ablation and Prolonged Survival in Pancreatic Cancer Murine Models
John Michael Bryant, Max Shotbolt, Emmanuel Stimphil, et al.
BMC Cancer
|
April 9, 2024
Habitat escalated adaptive therapy (HEAT): a phase 2 trial utilizing radiomic habitat-directed and genomic-adjusted radiation dose (GARD) optimization for high-grade soft tissue sarcoma
Arash O Naghavi, J M Bryant, Youngchul Kim, et al.
Page
of 7